Benitec Biopharma Inc. Announces Proposed Public Offering
Benitec Biopharma Inc. Announces Proposed Public Offering GlobeNewswire November 05, 2025 HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA- directed RNA interference (“ddRNAi”) “Silence and Replace” platform, today announced that it […]